Drug intelligence / Profile preview

Multigrip

Development stage: Unknown
Lead developer: Multilab Indústria e Comércio de Produtos Farmacêuticos
Modality: Small Molecules
Administration: Oral

Overview

Multigrip is a best-selling over-the-counter (OTC) cold and flu remedy, originally developed and marketed by the Brazilian drugmaker Multilab Industria e Comercio de Produtos Farmaceuticos. It is a combination drug containing Acetaminophen (an analgesic and antipyretic), Chlorpheniramine Maleate (an antihistamine), and Phenylephrine Hydrochloride (a nasal decongestant). Takeda Pharmaceutical Company acquired Multilab, including the Multigrip brand, to strengthen its position in the Brazilian market for branded generics and OTC products.

Brand names: Multigrip

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH1 (Histamine H1 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)ADRA1A (α1A)

Beyond the preview

Go deeper on Multigrip.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multigrip.

Explore the full profile